Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

The potential of anisotropic matrices as substrate for heart valve engineering.

Sohier J., Carubelli I., Sarathchandra P., Latif N., Chester AH., Yacoub MH.

Laboratory Study on Systemic / IV, published in Biomaterials (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biomaterials (2013)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
24314554
DOI
10.1016/j.biomaterials.2013.10.061
Citations
33

Abstract (original English)

Cells environment is increasingly recognized as an important function regulator through cell-matrix interactions. Extracellular matrix (ECM) anisotropy being a key component of heart valves properties, we have devised a method to create highly porous anisotropic nanofibrillar scaffolds and studied their suitability as cell-support and interactions with human adipose derived stem cells (hADSCs) and human valve interstitial cells (hVICs). Anisotropic nanofibrillar scaffolds were produced by a modified jet-spraying method that allows the formation of aligned nanofibres (600 nm) through air-stream diffraction of a polymer solution (poly (ε-caprolactone, PCL) and collection onto a variably rotating drum. The resulting matrices of high porosity (99%) mimicked valve mechanical anisotropy. Dynamically seeded hADSC and hVIC cultured on scaffolds up to 20 days revealed that hADSC and hVIC penetration within the matrices was improved by anisotropic organization. Within 10 days, cells populated the entire scaffolds thickness and produced ECM (collagen I, III and elastin). As a result, mechanical properties of the constructs were improved over culture, while remaining anisotropic. In contrast to isotropic matrices, anisotropy induced elongated hADSCs and hVICs morphology that followed nanofibres orientation. Interestingly, these morphological changes did not induce hADSC differentiation tow

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Biocompatible MaterialsCells, CulturedHeart ValvesHumansTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research